Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer
Conclusion Residual hypothyroid complaints in LT4-treated patients are specifically related to low FT3 concentrations. This supports an important role of FT3 for clinical decision making on dose adequacy, particularly in symptomatic athyreotic patients. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Larisch, Rolf Midgley, John E M Dietrich, Johannes W Hoermann, Rudolf Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Diabetes | Endocrinology | Hyperthyroidism | Hypothyroidism | Levothyroxine | Nutrition | Study | Synthroid | Thyroid | Thyroid Cancer